- Report
- May 2025
- 150 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- January 2026
- 194 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- February 2026
- 354 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- June 2025
- 185 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- June 2025
- 81 Pages
Global
From €3500EUR$4,281USD£3,144GBP
- Report
- October 2025
- 87 Pages
United States
From €4248EUR$4,850USD£3,687GBP
- Report
- November 2025
- 150 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- January 2026
- 186 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 180 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 199 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- February 2026
- 187 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1095EUR$1,250USD£950GBP
- Report
- June 2025
- 150 Pages
Global
From €2364EUR$2,699USD£2,052GBP
- Report
- November 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- February 2024
- 126 Pages
Global
From €2619EUR$2,990USD£2,273GBP
- Report
- May 2024
- 129 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- April 2023
- 110 Pages
Global
From €4160EUR$4,750USD£3,611GBP

The Intravenous Iron market is a segment of the Hematological Drugs market, which includes drugs used to treat anemia and other blood disorders. Intravenous Iron is a type of drug used to treat iron deficiency anemia, a condition in which the body does not have enough iron to produce healthy red blood cells. Intravenous Iron is administered directly into the bloodstream, allowing for a more rapid increase in iron levels than oral iron supplements.
Intravenous Iron is used in a variety of settings, including hospitals, clinics, and home care. It is often prescribed to patients who are unable to take oral iron supplements due to gastrointestinal issues or who require a more rapid increase in iron levels.
The Intravenous Iron market is highly competitive, with a number of companies offering products in this space. Some of the major players in the market include Vifor Pharma, Fresenius Kabi, American Regent, and B. Braun. Show Less Read more